Short Interest in BioNexus Gene Lab Corp. (NASDAQ:BGLC) Decreases By 38.3%

BioNexus Gene Lab Corp. (NASDAQ:BGLC) saw a large drop in short interest in the month of January. As of January 15th, there was short interest totaling 17,038 shares, a drop of 38.3% from the December 31st total of 27,606 shares. Based on an average daily trading volume, of 6,680 shares, the short-interest ratio is presently 2.6 days. Approximately 0.7% of the company’s stock are sold short. Approximately 0.7% of the company’s stock are sold short. Based on an average daily trading volume, of 6,680 shares, the short-interest ratio is presently 2.6 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of BioNexus Gene Lab in a research report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, BioNexus Gene Lab presently has a consensus rating of “Sell”.

BioNexus Gene Lab Stock Down 4.0%

NASDAQ BGLC opened at $2.65 on Friday. BioNexus Gene Lab has a 52 week low of $2.01 and a 52 week high of $15.60. The firm has a 50 day moving average of $3.94 and a two-hundred day moving average of $4.83. The stock has a market capitalization of $6.25 million, a PE ratio of -3.49 and a beta of 5.26.

About BioNexus Gene Lab

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.